Pertuzumab Market
According to Intent Market Research, the Pertuzumab Market is expected to grow from USD 9.2 billion in 2024-e at a CAGR of 7.4% to touch USD 14.1 billion by 2030. The Pertuzumab Market is dominated by key players such as, Pfizer Inc., Genentech (Roche), Merck & Co., Amgen Inc., and Bristol-Myers Squibb.